Table of Contents Global Hematologic Malignancies Market Research Report 2020, Forecast to 2025 1 Market Overview 1.1 Hematologic Malignancies Definition 1.1.1 Analysis of Macroeconomic Indicators 1.1.2 Years Considered 1.2 Hematologic Malignancies Segment by Type 1.2.1 Leukemia 1.2.2 Lymphoma 1.2.3 Multiple Myeloma 1.2.4 Others 1.3 Market Analysis by Application 1.3.1 Chemotherapy 1.3.2 Radiotherapy 1.3.3 Immunotherapy 1.3.4 Stem Cell Transplantation 1.3.5 Others 1.4 Overview of Global Hematologic Malignancies Market 1.4.1 Global Hematologic Malignancies Revenue (2015-2025) 1.4.2 Global Hematologic Malignancies Production and Capacity (2015-2025) 1.4.3 North America Hematologic Malignancies Status and Prospect (2015-2025) 1.4.4 Europe Hematologic Malignancies Status and Prospect (2015-2025) 1.4.5 Japan Hematologic Malignancies Status and Prospect (2014-2025) 1.4.6 China Hematologic Malignancies Status and Prospect (2015-2025) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 1.5.4 Porter's Five Forces Analysis 1.5.5 SWOT Analysis 1.6 Coronavirus Disease 2019 (Covid-19): Hematologic Malignancies Industry Impact 1.6.1 How the Covid-19 is Affecting the Hematologic Malignancies Industry 1.6.2 Hematologic Malignancies Business Impact Assessment - Covid-19 1.6.3 Market Trends and Hematologic Malignancies Potential Opportunities in the COVID-19 Landscape 1.6.4 Measures / Proposal against Covid-19 2 Global Hematologic Malignancies Market Competition by Manufacturer 2.1 Global Hematologic Malignancies Sales and Market Share by Manufacturer (2018-2020) 2.2 Global Hematologic Malignancies Revenue and Market Share by Manufacturer (2018-2020) 2.3 Global Hematologic Malignancies Industry Concentration Ratio (CR5 and HHI) 2.4 Top 5 Hematologic Malignancies Manufacturer Market Share 2.5 Top 10 Hematologic Malignancies Manufacturer Market Share 2.6 Date of Key Manufacturers Enter into Hematologic Malignancies Market 2.7 Key Manufacturers Hematologic Malignancies Product Offered 2.8 Mergers & Acquisitions Planning 3 Analysis of Hematologic Malignancies Industry Key Manufacturers 3.1 Pfizer, Inc. 3.1.1 Company Details 3.1.2 Product Information 3.1.3 Pfizer, Inc. Hematologic Malignancies Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.1.4 Main Business Overview 3.1.5 Pfizer, Inc. News 3.2 F. Hoffmann-LA Roche ltd 3.2.1 Company Details 3.2.2 Product Information 3.2.3 F. Hoffmann-LA Roche ltd Hematologic Malignancies Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.2.4 Main Business Overview 3.2.5 F. Hoffmann-LA Roche ltd News 3.3 Sanofi-Aventis 3.3.1 Company Details 3.3.2 Product Information 3.3.3 Sanofi-Aventis Hematologic Malignancies Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.3.4 Main Business Overview 3.3.5 Sanofi-Aventis News 3.4 Bristol-Myers Squibb Company 3.4.1 Company Details 3.4.2 Product Information 3.4.3 Bristol-Myers Squibb Company Hematologic Malignancies Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.4.4 Main Business Overview 3.4.5 Bristol-Myers Squibb Company News 3.5 AbbVie, Inc. 3.5.1 Company Details 3.5.2 Product Information 3.5.3 AbbVie, Inc. Hematologic Malignancies Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.5.4 Main Business Overview 3.5.5 AbbVie, Inc. News 3.6 Novartis AG 3.6.1 Company Details 3.6.2 Product Information 3.6.3 Novartis AG Hematologic Malignancies Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.6.4 Main Business Overview 3.6.5 Novartis AG News 3.7 GlaxoSmithKline PLC 3.7.1 Company Details 3.7.2 Product Information 3.7.3 GlaxoSmithKline PLC Hematologic Malignancies Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.7.4 Main Business Overview 3.7.5 GlaxoSmithKline PLC News 3.8 Celgene Corporation 3.8.1 Company Details 3.8.2 Product Information 3.8.3 Celgene Corporation Hematologic Malignancies Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.8.4 Main Business Overview 3.8.5 Celgene Corporation News 3.9 Johnson & Johnson Services, Inc. 3.9.1 Company Details 3.9.2 Product Information 3.9.3 Johnson & Johnson Services, Inc. Hematologic Malignancies Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.9.4 Main Business Overview 3.9.5 Johnson & Johnson Services, Inc. News 3.10 Takeda Pharmaceutical Company limited 3.10.1 Company Details 3.10.2 Product Information 3.10.3 Takeda Pharmaceutical Company limited Hematologic Malignancies Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.10.4 Main Business Overview 3.10.5 Takeda Pharmaceutical Company limited News 4 Global Hematologic Malignancies Market Size Categorized by Regions (2015-2020) 4.1 Global Hematologic Malignancies Sales Market Share by Region 4.2 Global Hematologic Malignancies Revenue Market Share by Region (2015-2019) 4.3 Global Hematologic Malignancies Sales, Revenue, Price and Gross Margin (2015-2020) 4.4 North America Hematologic Malignancies Market Size Detail 4.4.1 North America Hematologic Malignancies Sales Growth Rate (2015-2020) 4.4.2 North America Hematologic Malignancies Sales, Revenue, Price and Gross Margin (2015-2020) 4.5 Europe Hematologic Malignancies Market Size Detail 4.5.1 Europe Hematologic Malignancies Sales Growth Rate (2015-2020) 4.5.2 Europe Hematologic Malignancies Sales, Revenue, Price and Gross Margin (2015-2020) 4.6 Japan Hematologic Malignancies Market Size Detail 4.6.1 Japan Hematologic Malignancies Sales Growth Rate (2015-2020) 4.6.2 Japan Hematologic Malignancies Sales, Revenue, Price and Gross Margin (2015-2020) 4.7 China Hematologic Malignancies Market Size Detail 4.7.1 China Hematologic Malignancies Sales Growth Rate (2015-2020) 4.7.2 China Hematologic Malignancies Sales, Revenue, Price and Gross Margin (2015-2020) 5 Global Hematologic Malignancies Market Segment by Type 5.1 Global Hematologic Malignancies Revenue, Sales and Market Share by Type (2015-2020) 5.1.1 Global Hematologic Malignancies Sales and Market Share by Type (2015-2020) 5.1.2 Global Hematologic Malignancies Revenue and Market Share by Type (2015-2020) 5.2 Leukemia Sales Growth Rate and Price 5.2.1 Global Leukemia Sales Growth Rate (2015-2020) 5.2.2 Global Leukemia Price (2015-2020) 5.3 Lymphoma Sales Growth Rate and Price 5.3.1 Global Lymphoma Sales Growth Rate (2015-2020) 5.3.2 Global Lymphoma Price (2015-2020) 5.4 Multiple Myeloma Sales Growth Rate and Price 5.4.1 Global Multiple Myeloma Sales Growth Rate (2015-2020) 5.4.2 Global Multiple Myeloma Price (2015-2020) 5.5 Others Sales Growth Rate and Price 5.5.1 Global Others Sales Growth Rate (2015-2020) 5.5.2 Global Others Price (2015-2020) 6 Global Hematologic Malignancies Market Segment by Application 6.1 Global Hematologic Malignancies Sales Market Share by Application (2015-2020) 6.2 Chemotherapy Sales Growth Rate (2015-2020) 6.3 Radiotherapy Sales Growth Rate (2015-2020) 6.4 Immunotherapy Sales Growth Rate (2015-2020) 6.5 Stem Cell Transplantation Sales Growth Rate (2015-2020) 6.6 Others Sales Growth Rate (2015-2020) 7 Hematologic Malignancies Related Market Analysis 7.1 Upstream Analysis 7.1.1 Macro Analysis of Upstream Markets 7.1.2 Key Players in Upstream Markets 7.1.3 Upstream Market Trend Analysis 7.1.4 Hematologic Malignancies Manufacturing Cost Analysis 7.2 Downstream Market Analysis 7.2.1 Macro Analysis of Down Markets 7.2.2 Key Players in Down Markets 7.2.3 Downstream Market Trend Analysis 7.2.4 Sales Channel, Distributors, Traders and Dealers 8 Global Hematologic Malignancies Market Forecast 8.1 Global Hematologic Malignancies Sales, Revenue Forecast 8.1.1 Global Hematologic Malignancies Sales Growth Rate Forecast (2020-2025) 8.1.2 Global Hematologic Malignancies Revenue and Growth Rate Forecast (2020-2025) 8.1.3 Global Hematologic Malignancies Price and Trend Forecast (2020-2025) 8.2 Global Hematologic Malignancies Sales Forecast by Region (2020-2025) 8.2.1 North America Hematologic Malignancies Sales, Revenue Forecast (2020-2025) 8.2.2 Europe Hematologic Malignancies Sales, Revenue Forecast (2020-2025) 8.2.3 Japan Hematologic Malignancies Production, Revenue Forecast (2020-2025) 8.2.4 China Hematologic Malignancies Production, Revenue Forecast (2020-2025) 9 Research Findings and Conclusion 10 Appendix

List of Tables and Figures Figure Hematologic Malignancies Picture Table Global Hematologic Malignancies Sales by Type Figure Global Sales Market Share of Hematologic Malignancies by Product Type in 2019 Table Breakdown of Hematologic Malignancies by Company Type (Tier 1, Tier 2 and Tier 3) Figure Hematologic Malignancies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) Figure Leukemia Picture Figure Lymphoma Picture Figure Multiple Myeloma Picture Figure Others Picture Table Global Hematologic Malignancies Sales by Application Figure Global Hematologic Malignancies Sales Market Share by Application in 2019 Figure Chemotherapy Picture Figure Radiotherapy Picture Figure Immunotherapy Picture Figure Stem Cell Transplantation Picture Figure Others Picture Table Hematologic Malignancies Market Size Comparison by Region (2019-2025) (K Units) & (Million US$) Figure Global Hematologic Malignancies Revenue (Million US$) (2015-2025) Figure Global Hematologic Malignancies Production (K Units) (2015-2025) Figure North America Hematologic Malignancies Revenue (Million US$) Growth Rate (2015-2025) Figure Europe Hematologic Malignancies Revenue (Million US$) Growth Rate (2015-2025) Figure Japan Hematologic Malignancies Revenue (Million US$) Growth Rate (2014-2025) Figure China Hematologic Malignancies Revenue (Million US$) Growth Rate (2015-2025) Table Market Opportunities in Next Few Years Table Market Risks Analysis Table Market Drivers Figure Porter's Five Forces Analysis Table SWOT Analysis Table Global Hematologic Malignancies Sales by Manufacturer (2018-2020) Figure Global Hematologic Malignancies Sales Market Share by Manufacturer in 2019 Table Global Hematologic Malignancies Revenue by Manufacturer (2018-2020) Figure Global Hematologic Malignancies Revenue Market Share by Manufacturer in 2019 Table Global Hematologic Malignancies Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Top 5 Hematologic Malignancies Manufacturer (Revenue) Market Share in 2019 Figure Top 10 Hematologic Malignancies Manufacturer (Revenue) Market Share in 2019 Table Date of Key Manufacturers Enter into Hematologic Malignancies Market Table Key Manufacturers Hematologic Malignancies Product Type Table Mergers & Acquisitions Planning Table Pfizer, Inc. Company Profile Figure Hematologic Malignancies Product Picture and Specifications of Pfizer, Inc. Table Hematologic Malignancies Production, Price, Revenue and Gross Margin of 2018-2020 Figure Pfizer, Inc. Hematologic Malignancies Market Share (2018-2020) Table Pfizer, Inc. Main Business Table Pfizer, Inc. Recent Development Table F. Hoffmann-LA Roche ltd Company Profile Figure Hematologic Malignancies Product Picture and Specifications of F. Hoffmann-LA Roche ltd Table Hematologic Malignancies Production, Price, Revenue and Gross Margin of 2018-2020 Figure F. Hoffmann-LA Roche ltd Hematologic Malignancies Market Share (2018-2020) Table F. Hoffmann-LA Roche ltd Main Business Table F. Hoffmann-LA Roche ltd Recent Development Table Sanofi-Aventis Company Profile Figure Hematologic Malignancies Product Picture and Specifications of Sanofi-Aventis Table Hematologic Malignancies Production, Price, Revenue and Gross Margin of 2018-2020 Figure Sanofi-Aventis Hematologic Malignancies Market Share (2018-2020) Table Sanofi-Aventis Main Business Table Sanofi-Aventis Recent Development Table Bristol-Myers Squibb Company Company Profile Figure Hematologic Malignancies Product Picture and Specifications of Bristol-Myers Squibb Company Table Hematologic Malignancies Production, Price, Revenue and Gross Margin of 2018-2020 Figure Bristol-Myers Squibb Company Hematologic Malignancies Market Share (2018-2020) Table Bristol-Myers Squibb Company Main Business Table Bristol-Myers Squibb Company Recent Development Table AbbVie, Inc. Company Profile Figure Hematologic Malignancies Product Picture and Specifications of AbbVie, Inc. Table Hematologic Malignancies Production, Price, Revenue and Gross Margin of 2018-2020 Figure AbbVie, Inc. Hematologic Malignancies Market Share (2018-2020) Table AbbVie, Inc. Main Business Table AbbVie, Inc. Recent Development Table Novartis AG Company Profile Figure Hematologic Malignancies Product Picture and Specifications of Novartis AG Table Hematologic Malignancies Production, Price, Revenue and Gross Margin of 2018-2020 Figure Novartis AG Hematologic Malignancies Market Share (2018-2020) Table Novartis AG Main Business Table Novartis AG Recent Development Table GlaxoSmithKline PLC Company Profile Figure Hematologic Malignancies Product Picture and Specifications of GlaxoSmithKline PLC Table Hematologic Malignancies Production, Price, Revenue and Gross Margin of 2018-2020 Figure GlaxoSmithKline PLC Hematologic Malignancies Market Share (2018-2020) Table GlaxoSmithKline PLC Main Business Table GlaxoSmithKline PLC Recent Development Table Celgene Corporation Company Profile Figure Hematologic Malignancies Product Picture and Specifications of Celgene Corporation Table Hematologic Malignancies Production, Price, Revenue and Gross Margin of 2018-2020 Figure Celgene Corporation Hematologic Malignancies Market Share (2018-2020) Table Celgene Corporation Main Business Table Celgene Corporation Recent Development Table Johnson & Johnson Services, Inc. Company Profile Figure Hematologic Malignancies Product Picture and Specifications of Johnson & Johnson Services, Inc. Table Hematologic Malignancies Production, Price, Revenue and Gross Margin of 2018-2020 Figure Johnson & Johnson Services, Inc. Hematologic Malignancies Market Share (2018-2020) Table Johnson & Johnson Services, Inc. Main Business Table Johnson & Johnson Services, Inc. Recent Development Table Takeda Pharmaceutical Company limited Company Profile Figure Hematologic Malignancies Product Picture and Specifications of Takeda Pharmaceutical Company limited Table Hematologic Malignancies Production, Price, Revenue and Gross Margin of 2018-2020 Figure Takeda Pharmaceutical Company limited Hematologic Malignancies Market Share (2018-2020) Table Takeda Pharmaceutical Company limited Main Business Table Takeda Pharmaceutical Company limited Recent Development Table Global Hematologic Malignancies Sales (K Units) by Region (2015-2020) Table Global Hematologic Malignancies Sales Market Share by Region (2015-2019) Figure Global Hematologic Malignancies Sales Market Share by Region (2015-2019) Figure Global Hematologic Malignancies Sales Market Share by Region in 2018 Table Global Hematologic Malignancies Revenue (Million US$) by Region (2015-2020) Table Global Hematologic Malignancies Revenue Market Share by Region (2015-2020) Figure Global Hematologic Malignancies Revenue Market Share by Region (2015-2020) Figure Global Hematologic Malignancies Revenue Market Share by Region in 2019 Table Global Hematologic Malignancies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure North America Hematologic Malignancies Sales (K Units) Growth Rate (2015-2020) Figure Europe Hematologic Malignancies Sales (K Units) Growth Rate (2015-2020) Table Europe Hematologic Malignancies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure Japan Hematologic Malignancies Sales (K Units) Growth Rate (2015-2020) Table Japan Hematologic Malignancies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure China Hematologic Malignancies Sales (K Units) Growth Rate (2015-2020) Table China Hematologic Malignancies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table Global Hematologic Malignancies Sales by Type (2015-2020) Table Global Hematologic Malignancies Sales Market Share by Type (2015-2020) Figure Global Hematologic Malignancies Sales Market Share by Type in 2019 Table Global Hematologic Malignancies Revenue by Type (2015-2020) Table Global Hematologic Malignancies Revenue Market Share by Type (2015-2020) Figure Global Hematologic Malignancies Revenue Market Share by Type in 2019 Figure Global Leukemia Sales Growth Rate (2015-2025) Figure Global Leukemia Price (2015-2020) Figure Global Lymphoma Sales Growth Rate (2015-2025) Figure Global Lymphoma Price (2015-2020) Figure Global Multiple Myeloma Sales Growth Rate (2015-2025) Figure Global Multiple Myeloma Price (2015-2020) Figure Global Others Sales Growth Rate (2015-2025) Figure Global Others Price (2015-2020) Table Global Hematologic Malignancies Sales Market Share by Application (2015-2020) Figure Global Hematologic Malignancies Sales Market Share by Application in 2019 Figure Global Chemotherapy Sales Growth Rate (2015-2025) Figure Global Radiotherapy Sales Growth Rate (2015-2025) Figure Global Immunotherapy Sales Growth Rate (2015-2025) Figure Global Stem Cell Transplantation Sales Growth Rate (2015-2025) Figure Global Others Sales Growth Rate (2015-2025) Table Key Players of Upstream Markets Table Key Raw Materials Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Hematologic Malignancies Table Key Players of Downstream Markets Figure Sales Channel Figure Global Hematologic Malignancies Production (K Units) Growth Rate Forecast (2020-2025) Figure Global Hematologic Malignancies Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Global Hematologic Malignancies Price and Trend Forecast (2020-2025) Table Global Hematologic Malignancies Sales (K Units) Forecast by Region (2020-2025) Figure Global Hematologic Malignancies Production Market Share Forecast by Region (2020-2025) Figure North America Hematologic Malignancies Sales (K Units) Growth Rate Forecast (2020-2025) Figure North America Hematologic Malignancies Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Europe Hematologic Malignancies Sales (K Units) Growth Rate Forecast (2020-2025) Figure Europe Hematologic Malignancies Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Japan Hematologic Malignancies Production (K Units) Growth Rate Forecast (2020-2025) Figure Japan Hematologic Malignancies Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure China Hematologic Malignancies Production (K Units) Growth Rate Forecast (2020-2025) Figure China Hematologic Malignancies Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Methodology/Research Approach Figure Market Size Estimation Figure Author List